AI assistant
Sending…
Nykode Therapeutics ASA — Director's Dealing 2024
Mar 21, 2024
3695_dirs_2024-03-21_8d3e4491-31b4-44b4-8e2b-aa62465cafc4.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| 1 | Details of the person discharging managerial responsibilities | ||
|---|---|---|---|
| a) | Name | Birgitte Volck | |
| b) | Position | Board Member | |
| 2 | Reason for notification | ||
| a) | Initial notification/ | Initial | |
| Amendment | |||
| 3 | Details of issuer | ||
| a) | Name | Nykode Therapeutics ASA | |
| b) | LEI | 254900UKQHWYZJD22017 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
| a) | Description of the financial instrument, type of instrument |
Shares in Nykode Therapeutics ASA (ISIN: NO0010714785) | |
| b) | Nature of the transaction |
Acquisition of shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| NOK 15.276 | 20,311 | ||
| d) | Aggregated information | Price | NOK 15.276 |
| -Average price, | Volume | 20,311 | |
| aggregated volume and total amount |
Total amount | NOK 310,270.84 | |
| e) | Date of the transaction | 21.03.2024 | |
| f) | Place of the transaction | XOSL - Oslo Stock Exchange |
More from Nykode Therapeutics ASA
Interim / Quarterly Report
2026
May 27
Earnings Release
2026
May 27
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30